25% of U.S. Take-Private Market

Represent management sellers in 25% of active take-private deals in the U.S. market.

Vantage’s award-winning $9.2b data center transaction ​

Advised management on Vantage Data Centers’ historic $9.2b cross-border expansion and equity investment.​

$40b sale of Aligned Data Centers​

Advised the Aligned Data Centers management team on its $40b sale to a consortium of investors including BlackRock’s Global Infrastructure Partners.

Ranked 3rd U.S. PE M&A for Targets

Ranked 3rd (up from #8) by value in Mergermarket FY2025 league tables for advising U.S. targets and sellers in Private Equity M&A transactions.

$5.65b marina and superyacht servicing company

Represented founder and senior management team in $5.65b sale of largest U.S. marina and superyacht servicing business.

$6.4b satellite company

Represented management team in connection with take private transaction.

FuboTV and Hulu + Live TV combination

Advised the FuboTV management team on its business combination with Hulu + Live TV, creating the sixth-largest U.S. pay TV company.

$4b succession planning

Succession planning for founder’s stake in $4b AUM private equity fund.

Biologic dispute favorable settlement

For Sanofi/Regeneron in declaratory judgment patent suit against Genentech relating to EYLEA.

$2.2b sale of Novaria Group

Advised the management team of Novaria Group on its sale to Arcline Investment Management.

$12.6b bank acquisition

Advised NBHC management team on its acquisition of Vista Bancshares, Inc. and Vista Bank, creating a combined organization with approximately $12.6b in pro forma assets.

$10b crypto bankruptcy

Acted for largest unsecured creditors in liquidation of Three Arrows Capital in BVI & NY.

$8b cloud based software firm

Represented founder/CEO and management team in connection with take private transaction.

$7b IPO

Advised founder in IPO of $7b real estate tech company.

$4b founder sale

Advised founder and CEO on a $4b leadership transition and exit package at a multi-billion-dollar company.

$1b+ royalty dispute

Settled royalty claims against multi-billion-dollar royalty stream.

Hatch-Waxman patent litigation

Representing Ipsen in Hatch-Waxman patent litigation on its ONIVYDE pancreatic cancer treatment.

$1.25b settlement

Achieved $1.25b settlement for Forward Pharma in global patent dispute with Biogen.

$10b capital raises

Represented management team of data center business in connection with cross-border expansion and $10b in capital raises.

$4b equity dispute

Representing founders of large PE-owned portfolio company in a dispute over $4b in equity value.

$10b qui tam​

Representing participants in multi-billion-dollar false claims act / qui tam case.

$2b lawsuit

Represented main defendant in $2b lawsuit involving alleged sham transactions.

Defend Trade Secrets Act

Obtained return of thousands of stolen computer records by filing first DTSA injunction case in the U.S.